Company Background
Mr. Kenneth Kupits and Mr. Vincent LaStella founded Immunostics, Inc. in 1983 in Metuchen, NJ to provide clinical laboratories with quality microbiological, serological and immunological reagents and in vitro diagnostic test kits. Working closely with a community of professionals highly skilled in designing and developing diagnostic reagents and testing formats, Immunostics has become a recognized leader in developing innovative and cost effective test systems world wide.
In 1989, the company moved into its current office and laboratory facility with over 6,000 Sq. Ft. in Ocean, NJ. To meet our increasing sales demands, we have expanded our fecal occult blood test kit manufacturing, assembly and inspection areas. We are presently in the process of creating a state of the art lateral flow device production area. Additionally, we have increased our warehousing capacities and now occupy over 13,000 Sq. Ft. in three buildings, with plans to build a 15,000 Sq. Ft. addition in the coming year.
NICE DOING BUSINESS WITH YOU
At A Glance
We employ over 40 people with 7 professional level scientists and manufacturing engineers each with over 25 years experience in the design, development, manufacturing and marketing of in vitro diagnostic products.
Our product line includes over 30 products in four clinical areas: pregnancy testing, infectious and autoimmune testing, fecal occult blood testing (FOBT) and direct bacterial identification systems. Messrs. Kupits and LaStella were the originators of the first fecal occult blood slide test, Hemoccult, which was eventually sold to Smith Kline. Immunostics has enjoyed significant growth over the years through timely and innovative product developments. Please see our current product listing attached.
Product Launches & In The Works
Hema-Screen™ EZ-WIPE, the most user-friendly and convenient Guaiac test on the market. Hema-Screen™ CONFIRM, a rapid two-tiered approach for the testing of fecal occult blood utilizing the guaiac method and the option to test specifically for human hemoglobin using the same fecal specimen with our immunochemical test.
Our current product development projects include two innovative redesigned FOB test formats, Urine Sticks for the analysis of creatine, nitrites, pH, glutaraldehyde, etc., High Sensitivity CRP test for coronary disease markers, and line of secondary reference standards for serology, tumor markers, drugs of abuse and coronary markers.
